Trial · NCT04099641
Results by group22
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 22
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients With Treatment Emergent Adverse Events (TEAE) | Group 1 (CPI Naïve) | 61 | Participants | ||
| Number of Patients With Treatment Emergent Adverse Events (TEAE) | Group 2 (CPI Relapse) | 19 | Participants | ||
| Severity of Treatment Emergent Adverse Events (TEAE) | Group 1 (CPI Naïve) | At least one Grade 1 TEAE | 3 | Participants | |
| Severity of Treatment Emergent Adverse Events (TEAE) | Group 2 (CPI Relapse) | At least one Grade 1 TEAE | 4 | Participants | |
| Severity of Treatment Emergent Adverse Events (TEAE) | Group 1 (CPI Naïve) | At least one Grade 2 TEAE | 19 | Participants | |
| Severity of Treatment Emergent Adverse Events (TEAE) | Group 2 (CPI Relapse) | At least one Grade 2 TEAE | 2 | Participants | |
| Severity of Treatment Emergent Adverse Events (TEAE) | Group 1 (CPI Naïve) | At least one Grade 3 TEAE | 21 | Participants | |
| Severity of Treatment Emergent Adverse Events (TEAE) | Group 2 (CPI Relapse) | At least one Grade 3 TEAE | 8 | Participants | |
| Severity of Treatment Emergent Adverse Events (TEAE) | Group 1 (CPI Naïve) | At least one Grade 4 TEAE | 1 | Participants | |
| Severity of Treatment Emergent Adverse Events (TEAE) | Group 2 (CPI Relapse) | At least one Grade 4 TEAE | 0 | Participants | |
| Severity of Treatment Emergent Adverse Events (TEAE) | Group 1 (CPI Naïve) | At least one Grade 5 TEAE | 17 | Participants | |
| Severity of Treatment Emergent Adverse Events (TEAE) | Group 2 (CPI Relapse) | At least one Grade 5 TEAE | 5 | Participants | |
| Objective Response Rate (ORR) | Group 1 (CPI Naïve) | Complete Response | 2 | Participants | |
| Objective Response Rate (ORR) | Group 2 (CPI Relapse) | Complete Response | 0 | Participants | |
| Objective Response Rate (ORR) | Group 1 (CPI Naïve) | Partial Response | 6 | Participants | |
| Objective Response Rate (ORR) | Group 2 (CPI Relapse) | Partial Response | 1 | Participants | |
| Objective Response Rate (ORR) | Group 1 (CPI Naïve) | Stable Disease | 16 | Participants | |
| Objective Response Rate (ORR) | Group 2 (CPI Relapse) | Stable Disease | 9 | Participants | |
| Objective Response Rate (ORR) | Group 1 (CPI Naïve) | Progressive Disease | 31 | Participants | |
| Objective Response Rate (ORR) | Group 2 (CPI Relapse) | Progressive Disease | 8 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04099641/results